Rapidx Bio Company Profile, Contacts & Intelligence

Rapidx Bio Overview

Problem 1.4+ billion people are diagnosed with infectious diseases every year. 8 days is the average delay for a person to go from the first symptom to treatment leading to severe disease, causing 15 million+ avoidable deaths every year. We have developed an infectious disease detection technology that can reduce this symptom-to-treatment cycle from the 8 day average to under 30 minutes. How Our Technology Works And Its USP Our prototype uses fingernail sized lasers and gold nanorods to amplify pathogen DNA to provide unprocessed sample-to-result time of <5 minutes. Crucially, the plasmonic PCR process integrates/removes the need for crucial steps (such as cell lysis, extraction and purification) to detect pathogens from entirely unprocessed samples, enabling it to be used without the need for a healthcare professional or a technician. Using our fast, single-step, portable and high accuracy PCR, first in point-of-care settings and subsequently in point-of-need or patient-facing settings, we can help diagnose and treat patients 200x faster (from 8 days to a few mins) to prevent severe disease.

Headquarters

Laboratory, United Kingdom

Website

rapidx.bio

Industry

Medical And Diagnostic Laboratories

NAICS

Medical and Diagnostic Laboratories, Medical Laboratories

Rapidx Bio Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Rapidx Bio People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Rapidx Bio Workforce Composition

Seniority breakdown across 4 visible profiles.

Rapidx Bio Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to Rapidx Bio

Explore companies in related markets and compare their industry and employee estimates.